BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

North Star Investment Management Corp.'s Holding History (CIK: 0001342857)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 200 Value ($000) $1 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 200 Value ($000) $1 Avg Close $5.62 Range $4.82 - $7.75
Q1 2023
Shares 20,000 Value ($000) $167 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 367,300 Value ($000) $4,217 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 441,900 Value ($000) $5,568 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 441,900 Value ($000) $4,675 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 443,400 Value ($000) $7,210 Avg Close $16.04 Range $11.56 - $19.99
Q4 2021
Shares 449,800 Value ($000) $6,230 Avg Close $13.23 Range $10.72 - $15.77
Q3 2021
Shares 442,900 Value ($000) $6,364 Avg Close $15.77 Range $14.00 - $18.48
Q2 2021
Shares 436,690 Value ($000) $6,904 Avg Close $13.59 Range $9.23 - $17.74
Q1 2021
Shares 435,790 Value ($000) $4,432 Avg Close $10.31 Range $7.27 - $14.24
Q4 2020
Shares 300,190 Value ($000) $2,236 Avg Close $5.16 Range $3.36 - $8.99
Q3 2020
Shares 175,000 Value ($000) $601 Avg Close $4.29 Range $3.30 - $6.03
Q2 2020
Shares 40,000 Value ($000) $191 Avg Close $3.99 Range $1.80 - $6.29